Free Trial

ESSA Pharma (EPIX) News Today

→ Executive Order To Wipe Out Your Bank Accounts (From Oasis Gold) (Ad)
Free EPIX Stock Alerts
$5.36
-0.36 (-6.29%)
(As of 12:09 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends
June 7 at 11:24 PM | marketbeat.com
2,298,662 Shares in ESSA Pharma Inc. (NASDAQ:EPIX) Purchased by RTW Investments LP
RTW Investments LP purchased a new position in ESSA Pharma Inc. (NASDAQ:EPIX - Free Report) (TSE:EPI) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 2,298,662 shares of the company'
May 30, 2024 | prnewswire.com
ESSA Pharma to Present at the Jefferies Global Healthcare Conference
May 24, 2024 | marketbeat.com
ESSA Pharma (NASDAQ:EPIX) Share Price Passes Below Fifty Day Moving Average of $7.33
ESSA Pharma (NASDAQ:EPIX) Stock Price Crosses Below 50 Day Moving Average of $7.33
May 21, 2024 | finance.yahoo.com
Insider Stock Buying Reaches US$709.0k On ESSA Pharma
May 16, 2024 | marketbeat.com
Oppenheimer Reiterates "Outperform" Rating for ESSA Pharma (NASDAQ:EPIX)
Oppenheimer reissued an "outperform" rating and set a $17.00 target price on shares of ESSA Pharma in a report on Thursday.
May 14, 2024 | markets.businessinsider.com
Buy Rating Endorsed for ESSA Pharma on Robust Pipeline and Market Expansion Potential
May 14, 2024 | prnewswire.com
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2024
April 14, 2024 | marketbeat.com
Short Interest in ESSA Pharma Inc. (NASDAQ:EPIX) Drops By 13.5%
ESSA Pharma Inc. (NASDAQ:EPIX - Get Free Report) (TSE:EPI) was the recipient of a large drop in short interest in the month of March. As of March 31st, there was short interest totalling 802,800 shares, a drop of 13.5% from the March 15th total of 928,600 shares. Based on an average trading volume of 154,100 shares, the days-to-cover ratio is presently 5.2 days.
April 9, 2024 | finance.yahoo.com
ESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
April 9, 2024 | prnewswire.com
ESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
April 8, 2024 | finance.yahoo.com
ESSA Pharma (NASDAQ:EPIX) Is In A Strong Position To Grow Its Business
April 7, 2024 | investing.com
Essa Pharma COO sells shares worth over $5,500
April 5, 2024 | morningstar.com
ESSA Pharma Inc EPIX
March 16, 2024 | marketbeat.com
ESSA Pharma Inc. (NASDAQ:EPIX) Short Interest Update
ESSA Pharma Inc. (NASDAQ:EPIX - Get Free Report) (TSE:EPI) was the recipient of a significant decline in short interest during the month of February. As of February 29th, there was short interest totalling 979,400 shares, a decline of 13.3% from the February 14th total of 1,130,000 shares. Based on an average daily volume of 154,800 shares, the days-to-cover ratio is presently 6.3 days. Approximately 4.8% of the shares of the stock are sold short.
March 10, 2024 | finance.yahoo.com
EPIX Jul 2024 7.500 call
March 10, 2024 | finance.yahoo.com
EPIX Jul 2024 12.500 put
March 7, 2024 | prnewswire.com
ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
February 16, 2024 | marketbeat.com
Short Interest in ESSA Pharma Inc. (NASDAQ:EPIX) Grows By 5.2%
ESSA Pharma Inc. (NASDAQ:EPIX - Get Free Report) (TSE:EPI) was the target of a large increase in short interest in January. As of January 31st, there was short interest totalling 1,410,000 shares, an increase of 5.2% from the January 15th total of 1,340,000 shares. Based on an average daily trading volume, of 148,200 shares, the short-interest ratio is currently 9.5 days. Approximately 7.1% of the shares of the company are sold short.
February 14, 2024 | marketbeat.com
ESSA Pharma (NASDAQ:EPIX) Posts Quarterly Earnings Results, Beats Estimates By $0.03 EPS
ESSA Pharma (NASDAQ:EPIX - Get Free Report) (TSE:EPI) issued its quarterly earnings results on Tuesday. The company reported ($0.14) EPS for the quarter, beating the consensus estimate of ($0.17) by $0.03.
February 13, 2024 | benzinga.com
ESSA Pharma: Q1 Earnings Insights
February 13, 2024 | finance.yahoo.com
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2023
February 12, 2024 | marketbeat.com
ESSA Pharma Inc. (NASDAQ:EPIX) Shares Sold by Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB decreased its holdings in shares of ESSA Pharma Inc. (NASDAQ:EPIX - Free Report) (TSE:EPI) by 34.4% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 234,000 shares of
February 8, 2024 | finance.yahoo.com
ESSA Pharma Inc Executive Peter Virsik Sells 72,782 Shares
February 6, 2024 | finance.yahoo.com
ESSA Pharma to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
January 22, 2024 | finance.yahoo.com
ESSA Pharma Inc.'s (NASDAQ:EPIX) hedge funds investors lost 12% last week but have benefitted from longer-term gains
December 22, 2023 | marketbeat.com
Zacks Small Cap Comments on ESSA Pharma Inc.'s Q1 2024 Earnings (NASDAQ:EPIX)
ESSA Pharma Inc. (NASDAQ:EPIX - Free Report) (TSE:EPI) - Zacks Small Cap issued their Q1 2024 earnings per share (EPS) estimates for ESSA Pharma in a research note issued on Wednesday, December 20th. Zacks Small Cap analyst D. Bautz expects that the company will earn ($0.15) per share for the qua
December 20, 2023 | finance.yahoo.com
EPIX: Initial Data from Combination Trial of Masofaniten and Enzalutamide Expected in 2024…
December 19, 2023 | marketbeat.com
ESSA Pharma Inc. (NASDAQ:EPIX) CEO David Ross Parkinson Acquires 9,223 Shares
ESSA Pharma Inc. (NASDAQ:EPIX - Get Free Report) (TSE:EPI) CEO David Ross Parkinson acquired 9,223 shares of ESSA Pharma stock in a transaction dated Thursday, December 14th. The shares were bought at an average price of $2.30 per share, for a total transaction of $21,212.90. Following the transaction, the chief executive officer now owns 65,675 shares of the company's stock, valued at $151,052.50. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.
December 14, 2023 | benzinga.com
ESSA Pharma Stock (NASDAQ:EPIX) Earnings Dates and Earning Calls
December 13, 2023 | marketbeat.com
Jefferies Financial Group Raises ESSA Pharma (NASDAQ:EPIX) Price Target to $16.00
Jefferies Financial Group upped their price objective on shares of ESSA Pharma from $15.00 to $16.00 and gave the stock a "buy" rating in a research report on Wednesday.
December 13, 2023 | marketbeat.com
ESSA Pharma (NASDAQ:EPIX) Announces Earnings Results, Beats Estimates By $0.10 EPS
ESSA Pharma (NASDAQ:EPIX - Get Free Report) (TSE:EPI) posted its earnings results on Tuesday. The company reported ($0.12) earnings per share for the quarter, beating analysts' consensus estimates of ($0.22) by $0.10.
December 12, 2023 | benzinga.com
ESSA Pharma Stock (NASDAQ:EPIX) Dividends: History, Yield and Dates
December 12, 2023 | benzinga.com
Recap: ESSA Pharma Q4 Earnings
December 12, 2023 | finance.yahoo.com
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2023
December 11, 2023 | finance.yahoo.com
Bullish ESSA Pharma Insiders Loaded Up On US$1.19m Of Stock
November 24, 2023 | msn.com
ESSA Pharma director Franklin Berger buys common shares worth ~$133.3K
November 21, 2023 | finance.yahoo.com
ESSA Pharma to Present at the Piper Sandler 35th Annual Healthcare Conference
November 8, 2023 | finance.yahoo.com
ESSA Pharma to Present at the Jefferies London Healthcare Conference
October 31, 2023 | finance.yahoo.com
We Think ESSA Pharma (NASDAQ:EPIX) Can Afford To Drive Business Growth
October 30, 2023 | finance.yahoo.com
EPIX: Dose Escalation Data for Combination of Masofaniten (EPI-7386) and Enzalutamide Presented at PCF Retreat…
October 21, 2023 | finance.yahoo.com
ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the European Society of Medical Oncology 2023 Congress
September 15, 2023 | marketbeat.com
ESSA Pharma Inc. (NASDAQ:EPIX) Sees Large Decline in Short Interest
ESSA Pharma Inc. (NASDAQ:EPIX - Get Free Report) (TSE:EPI) was the recipient of a significant decline in short interest in August. As of August 31st, there was short interest totalling 30,000 shares, a decline of 42.2% from the August 15th total of 51,900 shares. Approximately 0.2% of the shares of the company are short sold. Based on an average daily trading volume, of 32,500 shares, the short-interest ratio is presently 0.9 days.
August 14, 2023 | finance.yahoo.com
EPIX: Phase 2 Trial of EPI-7386 in Combination with Enzalutamide to Initiate in Calendar 3Q23…
August 14, 2023 | finance.yahoo.com
ESSA Pharma Inc. (NASDAQ:EPIX) is definitely on the radar of hedge funds investors who own 39% of the company
August 8, 2023 | finance.yahoo.com
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2023
June 6, 2023 | finance.yahoo.com
ESSA Pharma Appoints Lauren Merendino to its Board of Directors
June 1, 2023 | finance.yahoo.com
ESSA Pharma to Present at 2023 Jefferies Healthcare Conference
May 24, 2023 | finance.yahoo.com
We're Hopeful That ESSA Pharma (NASDAQ:EPIX) Will Use Its Cash Wisely
May 18, 2023 | finance.yahoo.com
EPIX: Moving Towards Phase 2 Trial of EPI-7386 in Combination with Enzalutamide…
May 11, 2023 | finance.yahoo.com
ESSA Pharma to Present at JMP Securities Life Sciences Conference
Get ESSA Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for EPIX and its competitors with MarketBeat's FREE daily newsletter.

Executive Order To Wipe Out Your Bank Accounts (Ad)

Don't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of opportunity to protect your interests is closing fast.

Click Here To Get Your FREE Guide Now!

EPIX Media Mentions By Week

EPIX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

EPIX
News Sentiment
▼
1.67

0.76
▲
Average
Medical
News Sentiment

EPIX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

EPIX Articles
This Week
▼
1

1
▲
EPIX Articles
Average Week

Get ESSA Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for EPIX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:EPIX) was last updated on 6/10/2024 by MarketBeat.com Staff

From Our Partners
AI's Next Magnificent Seven
The Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.
The Oxford Club | Sponsored
Elon Musk’s Final Masterpiece: “X-9840”
The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Ju...
Paradigm Press | Sponsored
Who are Nvidia’s Silent Partners?
Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.
Weiss Ratings | Sponsored
[PDF Inside] Crypto's $1 Trillion 60-Day Boom + New 2024 Profit Strategy
The crypto industry is exploding and Chris Munch just released a new PDF detailing how you can potentially pro...
DeFi Distribution | Sponsored
Trump convicted... now what?
Unexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. B...
Stansberry Research | Sponsored
It's time to ween off Chinese lithium!
As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...
Smallcaps Daily | Sponsored
Top 5 Tech Stocks to Buy for 2024
The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...
Daily Market Alerts | Sponsored
Top 5 AI Stocks to Buy for 2024
The electric vehicle boom is accelerating – and fast.
Market Moving Trends | Sponsored